{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T07:02:44Z","timestamp":1775026964913,"version":"3.50.1"},"reference-count":159,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002996","name":"Dutch Heart Foundation","doi-asserted-by":"crossref","award":["2021T017"],"award-info":[{"award-number":["2021T017"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100919"],"award-info":[{"award-number":["82100919"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Heart Fail Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11897-025-00728-7","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T09:15:27Z","timestamp":1763025327000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Endosomal Mechanisms in Heart Failure Pathophysiology"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0234-438X","authenticated-orcid":false,"given":"Martijn F.","family":"Hoes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2278-8271","authenticated-orcid":false,"given":"Shujin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8808-2631","authenticated-orcid":false,"given":"Joost JFP","family":"Luiken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"728_CR1","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"T Vos","year":"2020","unstructured":"Vos T, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396:1204\u201322.","journal-title":"Lancet"},{"key":"728_CR2","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","volume":"6","author":"PA Heidenreich","year":"2013","unstructured":"Heidenreich PA, et al. Forecasting the impact of heart failure in the united states: a policy statement from the American heart association. Circ Hear Fail. 2013;6:606\u201319.","journal-title":"Circ Hear Fail"},{"key":"728_CR3","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1161\/CIRCRESAHA.119.313572","volume":"124","author":"MA Pfeffer","year":"2019","unstructured":"Pfeffer MA, Shah AM, Borlaug BA. Heart failure with preserved ejection fraction in perspective. Circ Res. 2019;124:1598\u2013617.","journal-title":"Circ Res"},{"key":"728_CR4","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S0140-6736(20)31824-9","volume":"396","author":"F Zannad","year":"2020","unstructured":"Zannad F, et al. SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials. Lancet. 2020;396:819\u201329.","journal-title":"Lancet"},{"key":"728_CR5","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1161\/CIRCULATIONAHA.116.023518","volume":"133","author":"JE Udelson","year":"2016","unstructured":"Udelson JE, Stevenson LW. The future of heart failure Diagnosis, Therapy, and management. Circulation. 2016;133:2671\u201386.","journal-title":"Circulation"},{"key":"728_CR6","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJV McMurray","year":"2014","unstructured":"McMurray JJV, et al. Angiotensin\u2013Neprilysin Inhibition versus Enalapril in heart failure. N Engl J Med. 2014;371:993\u20131004.","journal-title":"N Engl J Med"},{"key":"728_CR7","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/CRD.0000000000000484","volume":"32","author":"J Sreenivasan","year":"2024","unstructured":"Sreenivasan J, et al. Pharmacotherapies in heart failure with preserved ejection fraction: A systematic review and network Meta-Analysis. Cardiol Rev. 2024;32:114\u201323.","journal-title":"Cardiol Rev"},{"key":"728_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1136\/heartjnl-2018-313040","volume":"104","author":"C Otto","year":"2018","unstructured":"Otto C. M 2018 Heartbeat: is there any effective therapy for heart failure with preserved ejection fraction? Heart 104 361\u20132.","journal-title":"Heart"},{"key":"728_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012721.pub2","author":"N Martin","year":"2018","unstructured":"Martin N, Manoharan K, Thomas J, Davies C, Lumbers RT. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction. Cochrane Database Syst Rev. 2018. https:\/\/doi.org\/10.1002\/14651858.CD012721.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"728_CR10","doi-asserted-by":"crossref","unstructured":"Gheorghiade M et al. Developing new treatments for heart failure. Circ Hear Fail 2016;9.","DOI":"10.1161\/CIRCHEARTFAILURE.115.002727"},{"key":"728_CR11","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1194\/jlr.R082933","volume":"59","author":"JC Glatz","year":"2018","unstructured":"Glatz JC, Luiken JFP. Dynamic role of the transmembrane glycoprotein CD36 (SR-B2) in cellular fatty acid uptake and utilization. J Lipid Res. 2018;59:1084\u201393.","journal-title":"J Lipid Res"},{"key":"728_CR12","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3390\/metabo12070579","volume":"12","author":"S Wang","year":"2022","unstructured":"Wang S, et al. Endosomal v-ATPase as a sensor determining myocardial substrate preference. Metabolites. 2022;12:579.","journal-title":"Metabolites"},{"key":"728_CR13","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1152\/physrev.00011.2023","volume":"104","author":"JFC Glatz","year":"2024","unstructured":"Glatz JFC, Heather LC, Luiken JJ. F. P. CD36 as a gatekeeper of myocardial lipid metabolism and therapeutic target for metabolic disease. Physiol Rev. 2024;104:727\u201364.","journal-title":"Physiol Rev"},{"key":"728_CR14","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.2337\/db16-0727","volume":"66","author":"Y Liu","year":"2017","unstructured":"Liu Y, et al. Palmitate-Induced Vacuolar-Type H+-ATPase Inhibition feeds forward into insulin resistance and contractile dysfunction. Diabetes. 2017;66:1521\u201334.","journal-title":"Diabetes"},{"key":"728_CR15","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.molonc.2016.01.003","volume":"10","author":"A Kulshrestha","year":"2016","unstructured":"Kulshrestha A, et al. Selective Inhibition of tumor cell associated Vacuolar-ATPase \u2018a2\u2019 isoform overcomes cisplatin resistance in ovarian cancer cells. Mol Oncol. 2016;10:789\u2013805.","journal-title":"Mol Oncol"},{"key":"728_CR16","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1021\/jacs.6b12511","volume":"139","author":"Y-C Chen","year":"2017","unstructured":"Chen Y-C, et al. Covalent modulators of the vacuolar ATPase. J Am Chem Soc. 2017;139:639\u201342.","journal-title":"J Am Chem Soc"},{"key":"728_CR17","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/eurjhf\/hfs192","volume":"15","author":"MA Schroeder","year":"2013","unstructured":"Schroeder MA, et al. Hyperpolarized 13\u00a0C magnetic resonance reveals early- and late\u2010onset changes to in vivo pyruvate metabolism in the failing heart. Eur J Heart Fail. 2013;15:130\u201340.","journal-title":"Eur J Heart Fail"},{"key":"728_CR18","doi-asserted-by":"publisher","first-page":"165579","DOI":"10.1016\/j.bbadis.2019.165579","volume":"1866","author":"JFC Glatz","year":"2020","unstructured":"Glatz JFC, et al. Re-balancing cellular energy substrate metabolism to mend the failing heart. Biochim Biophys Acta - Mol Basis Dis. 2020;1866:165579.","journal-title":"Biochim Biophys Acta - Mol Basis Dis"},{"key":"728_CR19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","volume":"62","author":"WJ Paulus","year":"2013","unstructured":"Paulus WJ, Tschope C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62:263\u201371.","journal-title":"J Am Coll Cardiol"},{"key":"728_CR20","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia G, Hill MA, Sowers JR. Diabetic cardiomyopathy. Circ Res. 2018;122:624\u201338.","journal-title":"Circ Res"},{"key":"728_CR21","doi-asserted-by":"publisher","first-page":"18148","DOI":"10.1074\/jbc.RA120.015216","volume":"295","author":"NN Turan","year":"2020","unstructured":"Turan NN, et al. The endosomal trafficking regulator LITAF controls the cardiac Nav1.5 channel via the ubiquitin ligase NEDD4-2. J Biol Chem. 2020;295:18148\u201359.","journal-title":"J Biol Chem"},{"key":"728_CR22","doi-asserted-by":"crossref","unstructured":"Curran J, Makara MA, Mohler PJ. Endosome-based protein trafficking and Ca2\u2009+\u2009homeostasis in the heart. Front Physiol 2015;6.","DOI":"10.3389\/fphys.2015.00034"},{"key":"728_CR23","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/14737159.2017.1266939","volume":"17","author":"HG Booij","year":"2017","unstructured":"Booij HG, Koning AM, van Goor H, de Boer RA, Westenbrink BD. Selecting heart failure patients for metabolic interventions. Expert Rev Mol Diagn. 2017;17:141\u201352.","journal-title":"Expert Rev Mol Diagn"},{"key":"728_CR24","doi-asserted-by":"publisher","first-page":"H768","DOI":"10.1152\/ajpheart.00820.2016","volume":"313","author":"M Ruiz","year":"2017","unstructured":"Ruiz M, et al. Circulating acylcarnitine profile in human heart failure: a surrogate of fatty acid metabolic dysregulation in mitochondria and beyond. Am J Physiol Circ Physiol. 2017;313:H768\u201381.","journal-title":"Am J Physiol Circ Physiol"},{"key":"728_CR25","doi-asserted-by":"crossref","unstructured":"Wurtz P et al. Abstract 18179: metabolic biomarker signatures for incident heart failure hospitalisation compared to different types of cardiovascular events: evidence from NMR metabolomics in 250,000 individuals. Circulation 2023;148.","DOI":"10.1161\/circ.148.suppl_1.18179"},{"key":"728_CR26","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/ejhf.2339","volume":"23","author":"B Moura","year":"2021","unstructured":"Moura B, et al. Integration of imaging and Circulating biomarkers in heart failure: a consensus document by the biomarkers and imaging study groups of the heart failure association of the European society of cardiology. Eur J Heart Fail. 2021;23:1577\u201396.","journal-title":"Eur J Heart Fail"},{"key":"728_CR27","doi-asserted-by":"publisher","first-page":"4867","DOI":"10.3390\/ijms24054867","volume":"24","author":"A Chu","year":"2023","unstructured":"Chu A, et al. Characterization of a PIP binding site in the N-Terminal domain of V-ATPase a4 and its role in plasma membrane association. Int J Mol Sci. 2023;24:4867.","journal-title":"Int J Mol Sci"},{"key":"728_CR28","doi-asserted-by":"crossref","unstructured":"Mitra C, Kane PM. Interactions between the aNT domains of human V-ATPases and phosphatidylinositol phosphate lipids. FASEB J 2022;36.","DOI":"10.1096\/fasebj.2022.36.S1.R4651"},{"key":"728_CR29","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nrm2272","volume":"8","author":"M Forgac","year":"2007","unstructured":"Forgac M. Vacuolar atpases: rotary proton pumps in physiology and pathophysiology. Nat Rev Mol Cell Biol. 2007;8:917\u201329.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"728_CR30","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1161\/CIRCRESAHA.123.322910","volume":"134","author":"S Wang","year":"2024","unstructured":"Wang S, et al. Glycolysis-Mediated activation of v-ATPase by nicotinamide mononucleotide ameliorates Lipid-Induced cardiomyopathy by repressing the CD36-TLR4 axis. Circ Res. 2024;134:505\u201325.","journal-title":"Circ Res"},{"key":"728_CR31","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1083\/jcb.200604016","volume":"174","author":"G Csord\u00e1s","year":"2006","unstructured":"Csord\u00e1s G, et al. Structural and functional features and significance of the physical linkage between ER and mitochondria. J Cell Biol. 2006;174:915\u201321.","journal-title":"J Cell Biol"},{"key":"728_CR32","doi-asserted-by":"publisher","first-page":"8927","DOI":"10.1038\/s41598-021-87876-7","volume":"11","author":"AD Juhl","year":"2021","unstructured":"Juhl AD, et al. Quantitative imaging of membrane contact sites for sterol transfer between endo-lysosomes and mitochondria in living cells. Sci Rep. 2021;11:8927.","journal-title":"Sci Rep"},{"key":"728_CR33","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.mito.2019.05.003","volume":"49","author":"K Todkar","year":"2019","unstructured":"Todkar K, Chikhi L, Germain M. Mitochondrial interaction with the endosomal compartment in endocytosis and mitochondrial transfer. Mitochondrion. 2019;49:284\u20138.","journal-title":"Mitochondrion"},{"key":"728_CR34","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nature22369","volume":"546","author":"AM Valm","year":"2017","unstructured":"Valm AM, et al. Applying systems-level spectral imaging and analysis to reveal the organelle interactome. Nature. 2017;546:162\u20137.","journal-title":"Nature"},{"key":"728_CR35","doi-asserted-by":"crossref","unstructured":"Westenbrink BD et al. Mitochondrial reprogramming induced by CaMKII\u03b4 mediates hypertrophy decompensation. Circ Res 2015;116.","DOI":"10.1161\/CIRCRESAHA.116.304682"},{"key":"728_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.isci.2018.08.012","volume":"7","author":"R Conrad","year":"2018","unstructured":"Conrad R, et al. Rapid turnover of the cardiac L-Type CaV1.2 channel by endocytic recycling regulates its cell surface availability. iScience. 2018;7:1\u201315.","journal-title":"iScience"},{"key":"728_CR37","doi-asserted-by":"publisher","unstructured":"Negri S, Faris P, Moccia F. Endolysosomal Ca2\u2009+\u2009signaling in cardiovascular health and disease. in 203\u201369, 2021. https:\/\/doi.org\/10.1016\/bs.ircmb.2021.03.001","DOI":"10.1016\/bs.ircmb.2021.03.001"},{"key":"728_CR38","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1113\/JP271332","volume":"594","author":"V Garc\u00eda-R\u00faa","year":"2016","unstructured":"Garc\u00eda-R\u00faa V, et al. Endolysosomal two-pore channels regulate autophagy in cardiomyocytes. J Physiol. 2016;594:3061\u201377.","journal-title":"J Physiol"},{"key":"728_CR39","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1080\/14728222.2022.2067479","volume":"26","author":"MM Hulsurkar","year":"2022","unstructured":"Hulsurkar MM, Lahiri SK, Karch J, Wang MC, Wehrens XHT. Targeting calcium-mediated inter-organellar crosstalk in cardiac diseases. Expert Opin Ther Targets. 2022;26:303\u201317.","journal-title":"Expert Opin Ther Targets"},{"key":"728_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.tcm.2012.03.002","volume":"21","author":"M Kohlhaas","year":"2011","unstructured":"Kohlhaas M, Maack C. Interplay of defective Excitation-Contraction Coupling, energy Starvation, and oxidative stress in heart failure. Trends Cardiovasc Med. 2011;21:69\u201373.","journal-title":"Trends Cardiovasc Med"},{"key":"728_CR41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.yjmcc.2020.08.018","volume":"148","author":"TG Martin","year":"2020","unstructured":"Martin TG, Kirk JA. Under construction: the dynamic assembly, maintenance, and degradation of the cardiac sarcomere. J Mol Cell Cardiol. 2020;148:89\u2013102.","journal-title":"J Mol Cell Cardiol"},{"key":"728_CR42","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1021\/acschembio.8b00656","volume":"14","author":"AC Wang","year":"2019","unstructured":"Wang AC, et al. Previously uncharacterized Vacuolar-type ATPase binding site discovered from structurally similar compounds with distinct mechanisms of action. ACS Chem Biol. 2019;14:20\u20136.","journal-title":"ACS Chem Biol"},{"key":"728_CR43","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.3390\/molecules22091559","volume":"22","author":"R Patil","year":"2017","unstructured":"Patil R, et al. Identification of novel Bisbenzimidazole derivatives as anticancer vacuolar (H+)-ATPase inhibitors. Molecules. 2017;22:1559.","journal-title":"Molecules"},{"key":"728_CR44","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.chembiol.2020.06.011","volume":"27","author":"Y Wang","year":"2020","unstructured":"Wang Y, et al. Pharmacological targeting of vacuolar H+-ATPase via subunit V1G combats Multidrug-Resistant cancer. Cell Chem Biol. 2020;27:1359\u2013e13708.","journal-title":"Cell Chem Biol"},{"key":"728_CR45","doi-asserted-by":"crossref","unstructured":"McLelland G-L et al. Mfn2 ubiquitination by PINK1\/parkin gates the p97-dependent release of ER from mitochondria to drive mitophagy. Elife 2018;7.","DOI":"10.7554\/eLife.32866"},{"key":"728_CR46","doi-asserted-by":"publisher","unstructured":"Hsu F et al. Rab5 and Alsin regulate stress-activated cytoprotective signaling on mitochondria. at https:\/\/doi.org\/10.1101\/200428\u00a02017.","DOI":"10.1101\/200428"},{"key":"728_CR47","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1038\/s41467-020-17451-7","volume":"11","author":"Y Elbaz-Alon","year":"2020","unstructured":"Elbaz-Alon Y, et al. PDZD8 interacts with protrudin and Rab7 at ER-late endosome membrane contact sites associated with mitochondria. Nat Commun. 2020;11:3645.","journal-title":"Nat Commun"},{"key":"728_CR48","doi-asserted-by":"publisher","first-page":"66","DOI":"10.12997\/jla.2020.9.1.66","volume":"9","author":"JFC Glatz","year":"2020","unstructured":"Glatz JFC, Luiken JJFP, Nabben M. CD36 (SR-B2) as a target to treat lipid Overload-Induced cardiac dysfunction. J Lipid Atheroscler. 2020;9:66.","journal-title":"J Lipid Atheroscler"},{"key":"728_CR49","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1126\/science.7504322","volume":"262","author":"AS Asch","year":"1993","unstructured":"Asch AS, et al. Analysis of CD36 binding domains: ligand specificity controlled by dephosphorylation of an ectodomain. Sci (80-). 1993;262:1436\u201340.","journal-title":"Sci (80-)"},{"key":"728_CR50","doi-asserted-by":"publisher","first-page":"22315","DOI":"10.1074\/jbc.271.37.22315","volume":"271","author":"N Tao","year":"1996","unstructured":"Tao N, Wagner SJ, Lublin DM. CD36 is palmitoylated on both N- and C-terminal cytoplasmic Tails. J Biol Chem. 1996;271:22315\u201320.","journal-title":"J Biol Chem"},{"key":"728_CR51","doi-asserted-by":"publisher","first-page":"4765","DOI":"10.1038\/s41467-020-18565-8","volume":"11","author":"J-W Hao","year":"2020","unstructured":"Hao J-W, et al. CD36 facilitates fatty acid uptake by dynamic palmitoylation-regulated endocytosis. Nat Commun. 2020;11:4765.","journal-title":"Nat Commun"},{"key":"728_CR52","doi-asserted-by":"publisher","first-page":"13578","DOI":"10.1074\/jbc.M800008200","volume":"283","author":"J Smith","year":"2008","unstructured":"Smith J, Su X, El-Maghrabi R, Stahl PD, Abumrad NA. Opposite regulation of CD36 ubiquitination by fatty acids and insulin. J Biol Chem. 2008;283:13578\u201385.","journal-title":"J Biol Chem"},{"key":"728_CR53","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1007\/s00125-010-1832-7","volume":"53","author":"RW Schwenk","year":"2010","unstructured":"Schwenk RW, et al. Requirement for distinct vesicle-associated membrane proteins in insulin- and AMP-activated protein kinase (AMPK)-induced translocation of GLUT4 and CD36 in cultured cardiomyocytes. Diabetologia. 2010;53:2209\u201319.","journal-title":"Diabetologia"},{"key":"728_CR54","doi-asserted-by":"publisher","first-page":"C1549","DOI":"10.1152\/ajpcell.00334.2009","volume":"298","author":"LKM Steinbusch","year":"2010","unstructured":"Steinbusch LKM, et al. Differential regulation of cardiac glucose and fatty acid uptake by endosomal pH and actin filaments. Am J Physiol Physiol. 2010;298:C1549\u201359.","journal-title":"Am J Physiol Physiol"},{"key":"728_CR55","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/ni.1836","volume":"11","author":"CR Stewart","year":"2010","unstructured":"Stewart CR, et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol. 2010;11:155\u201361.","journal-title":"Nat Immunol"},{"key":"728_CR56","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/sj.emboj.7600991","volume":"25","author":"H Husebye","year":"2006","unstructured":"Husebye H, et al. Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity. EMBO J. 2006;25:683\u201392.","journal-title":"EMBO J"},{"key":"728_CR57","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00018-020-03656-y","volume":"78","author":"A Ciesielska","year":"2021","unstructured":"Ciesielska A, Matyjek M, Kwiatkowska K. TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling. Cell Mol Life Sci. 2021;78:1233\u201361.","journal-title":"Cell Mol Life Sci"},{"key":"728_CR58","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.cmet.2010.09.010","volume":"12","author":"TA Seimon","year":"2010","unstructured":"Seimon TA, et al. Atherogenic lipids and lipoproteins trigger CD36-TLR2-Dependent apoptosis in macrophages undergoing Endoplasmic reticulum stress. Cell Metab. 2010;12:467\u201382.","journal-title":"Cell Metab"},{"key":"728_CR59","doi-asserted-by":"publisher","first-page":"31002","DOI":"10.1074\/jbc.M602794200","volume":"281","author":"M Triantafilou","year":"2006","unstructured":"Triantafilou M, et al. Membrane sorting of Toll-like receptor (TLR)-2\/6 and TLR2\/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J Biol Chem. 2006;281:31002\u201311.","journal-title":"J Biol Chem"},{"key":"728_CR60","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.omtn.2018.02.003","volume":"11","author":"AM de Groot","year":"2018","unstructured":"de Groot AM, et al. Immunogenicity testing of lipidoids in vitro and in silico: modulating Lipidoid-Mediated TLR4 activation by nanoparticle design. Mol Ther - Nucleic Acids. 2018;11:159\u201369.","journal-title":"Mol Ther - Nucleic Acids"},{"key":"728_CR61","doi-asserted-by":"crossref","unstructured":"Metwally H et al. Noncanonical STAT1 phosphorylation expands its transcriptional activity into promoting LPS-induced IL-6 and IL-12p40 production. Sci Signal 2020;13.","DOI":"10.1126\/scisignal.aay0574"},{"key":"728_CR62","doi-asserted-by":"publisher","first-page":"36235","DOI":"10.1074\/jbc.M400566200","volume":"279","author":"SE Campbell","year":"2004","unstructured":"Campbell SE, et al. A novel function for fatty acid translocase (FAT)\/CD36. J Biol Chem. 2004;279:36235\u201341.","journal-title":"J Biol Chem"},{"key":"728_CR63","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1042\/BJ20101861","volume":"437","author":"BK Smith","year":"2011","unstructured":"Smith BK, et al. FAT\/CD36 is located on the outer mitochondrial membrane, upstream of long-chain acyl-CoA synthetase, and regulates palmitate oxidation. Biochem J. 2011;437:125\u201334.","journal-title":"Biochem J"},{"key":"728_CR64","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1748-1716.2008.01878.x","volume":"194","author":"GP Holloway","year":"2008","unstructured":"Holloway GP, Luiken JJFP, Glatz JFC, Spriet LL, Bonen A. Contribution of FAT\/CD36 to the regulation of skeletal muscle fatty acid oxidation: an overview. Acta Physiol. 2008;194:293\u2013309.","journal-title":"Acta Physiol"},{"key":"728_CR65","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.abb.2007.08.020","volume":"467","author":"KL King","year":"2007","unstructured":"King KL, et al. Fatty acid oxidation in cardiac and skeletal muscle mitochondria is unaffected by deletion of CD36. Arch Biochem Biophys. 2007;467:234\u20138.","journal-title":"Arch Biochem Biophys"},{"key":"728_CR66","doi-asserted-by":"crossref","unstructured":"Melis M et al. Polymorphism rs1761667 in the CD36 gene is associated to changes in fatty acid metabolism and Circulating endocannabinoid levels distinctively in normal weight and obese subjects. Front Physiol 2017;8.","DOI":"10.3389\/fphys.2017.01006"},{"key":"728_CR67","doi-asserted-by":"publisher","first-page":"e1008287","DOI":"10.1371\/journal.pgen.1008287","volume":"15","author":"N Madan","year":"2019","unstructured":"Madan N, et al. Functionalization of CD36 cardiovascular disease and expression associated variants by interdisciplinary high throughput analysis. PLOS Genet. 2019;15:e1008287.","journal-title":"PLOS Genet"},{"key":"728_CR68","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1093\/hmg\/ddn060","volume":"17","author":"L Love-Gregory","year":"2008","unstructured":"Love-Gregory L, et al. Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol. Hum Mol Genet. 2008;17:1695\u2013704.","journal-title":"Hum Mol Genet"},{"key":"728_CR69","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/hmg\/ddq449","volume":"20","author":"L Love-Gregory","year":"2011","unstructured":"Love-Gregory L, et al. Common CD36 SNPs reduce protein expression and May contribute to a protective atherogenic profile. Hum Mol Genet. 2011;20:193\u2013201.","journal-title":"Hum Mol Genet"},{"key":"728_CR70","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1210\/jc.2016-1294","volume":"101","author":"CA Shibao","year":"2016","unstructured":"Shibao CA, et al. A common CD36 variant influences endothelial function and response to treatment with phosphodiesterase 5 Inhibition. J Clin Endocrinol Metab. 2016;101:2751\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"728_CR71","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.yjmcc.2011.04.001","volume":"51","author":"B Lauzier","year":"2011","unstructured":"Lauzier B, et al. Post-translational modifications, a key process in CD36 function: lessons from the spontaneously hypertensive rat heart. J Mol Cell Cardiol. 2011;51:99\u2013108.","journal-title":"J Mol Cell Cardiol"},{"key":"728_CR72","doi-asserted-by":"publisher","first-page":"14612","DOI":"10.1038\/ncomms14612","volume":"8","author":"MB Bagh","year":"2017","unstructured":"Bagh MB, et al. Misrouting of v-ATPase subunit V0a1 dysregulates lysosomal acidification in a neurodegenerative lysosomal storage disease model. Nat Commun. 2017;8:14612.","journal-title":"Nat Commun"},{"key":"728_CR73","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.molcel.2020.09.029","volume":"80","author":"L Wang","year":"2020","unstructured":"Wang L, Wu D, Robinson CV, Wu H, Fu T-M. Structures of a complete human V-ATPase reveal mechanisms of its assembly. Mol Cell. 2020;80:501\u2013e5113.","journal-title":"Mol Cell"},{"key":"728_CR74","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.arr.2016.05.004","volume":"32","author":"DJ Colacurcio","year":"2016","unstructured":"Colacurcio DJ, Nixon RA. Disorders of lysosomal acidification\u2014The emerging role of v-ATPase in aging and neurodegenerative disease. Ageing Res Rev. 2016;32:75\u201388.","journal-title":"Ageing Res Rev"},{"key":"728_CR75","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1042\/BJ20120060","volume":"448","author":"Y Angin","year":"2012","unstructured":"Angin Y, et al. CD36 Inhibition prevents lipid accumulation and contractile dysfunction in rat cardiomyocytes. Biochem J. 2012;448:43\u201353.","journal-title":"Biochem J"},{"key":"728_CR76","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1038\/s41467-020-15978-3","volume":"11","author":"Y Wang","year":"2020","unstructured":"Wang Y, et al. MD2 activation by direct AGE interaction drives inflammatory diabetic cardiomyopathy. Nat Commun. 2020;11:2148.","journal-title":"Nat Commun"},{"key":"728_CR77","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41419-021-03813-6","volume":"12","author":"Y Hou","year":"2021","unstructured":"Hou Y, et al. CD36 promotes NLRP3 inflammasome activation via the MtROS pathway in renal tubular epithelial cells of diabetic kidneys. Cell Death Dis. 2021;12:523.","journal-title":"Cell Death Dis"},{"key":"728_CR78","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.freeradbiomed.2014.08.007","volume":"76","author":"S Kotla","year":"2014","unstructured":"Kotla S, Singh NK, Traylor JG, Orr AW, Rao G. N. ROS-dependent Syk and Pyk2-mediated STAT1 activation is required for 15(S)-hydroxyeicosatetraenoic acid-induced CD36 expression and foam cell formation. Free Radic Biol Med. 2014;76:147\u201362.","journal-title":"Free Radic Biol Med"},{"key":"728_CR79","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.4049\/jimmunol.1800389","volume":"202","author":"GVRK Prasad","year":"2019","unstructured":"Prasad GVRK, Dhar V, Mukhopadhaya A. Vibrio cholerae OmpU mediates CD36-Dependent reactive oxygen species generation triggering an additional pathway of MAPK activation in macrophages. J Immunol. 2019;202:2431\u201350.","journal-title":"J Immunol"},{"key":"728_CR80","doi-asserted-by":"crossref","unstructured":"Park SJ et al. Molecular mechanisms of biogenesis of apoptotic exosome-like vesicles and their roles as damage-associated molecular patterns. Proc Natl Acad Sci. 2018;115.","DOI":"10.1073\/pnas.1811432115"},{"key":"728_CR81","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1210\/jc.2011-3408","volume":"97","author":"C Piperi","year":"2012","unstructured":"Piperi C, Adamopoulos C, Dalagiorgou G, Diamanti-Kandarakis E, Papavassiliou AG. Crosstalk between advanced glycation and Endoplasmic reticulum stress: emerging therapeutic targeting for metabolic diseases. J Clin Endocrinol Metab. 2012;97:2231\u201342.","journal-title":"J Clin Endocrinol Metab"},{"key":"728_CR82","doi-asserted-by":"publisher","first-page":"101293","DOI":"10.1016\/j.molmet.2021.101293","volume":"53","author":"S Wang","year":"2021","unstructured":"Wang S, et al. Specific amino acid supplementation rescues the heart from lipid overload-induced insulin resistance and contractile dysfunction by targeting the endosomal mTOR\u2013v-ATPase axis. Mol Metab. 2021;53:101293.","journal-title":"Mol Metab"},{"key":"728_CR83","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.semcdb.2017.08.012","volume":"74","author":"E Szymanska","year":"2018","unstructured":"Szymanska E, Budick-Harmelin N, Miaczynska M. Endosomal sort of signaling control: the role of ESCRT machinery in regulation of receptor-mediated signaling pathways. Semin Cell Dev Biol. 2018;74:11\u201320.","journal-title":"Semin Cell Dev Biol"},{"key":"728_CR84","doi-asserted-by":"publisher","first-page":"6074","DOI":"10.3390\/ijms21176074","volume":"21","author":"MJ O\u2019Sullivan","year":"2020","unstructured":"O\u2019Sullivan MJ, Lindsay AJ. The endosomal recycling Pathway\u2014At the crossroads of the cell. Int J Mol Sci. 2020;21:6074.","journal-title":"Int J Mol Sci"},{"key":"728_CR85","doi-asserted-by":"publisher","first-page":"11600","DOI":"10.1038\/ncomms11600","volume":"7","author":"EJR Jansen","year":"2016","unstructured":"Jansen EJR, et al. ATP6AP1 deficiency causes an immunodeficiency with hepatopathy, cognitive impairment and abnormal protein glycosylation. Nat Commun. 2016;7:11600.","journal-title":"Nat Commun"},{"key":"728_CR86","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/hmg\/5.5.659","volume":"5","author":"EY Chen","year":"1996","unstructured":"Chen EY, et al. Long-range sequence analysis in Xq28: thirteen known and six candidate genes in 219.4\u00a0kb of high GC DNA between the RCP\/GCP and G6PD loci. Hum Mol Genet. 1996;5:659\u201368.","journal-title":"Hum Mol Genet"},{"key":"728_CR87","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/jimd.12237","volume":"43","author":"N Ondruskova","year":"2020","unstructured":"Ondruskova N, et al. Severe phenotype of ATP6AP1-CDG in two siblings with a novel mutation leading to a differential tissue-specific ATP6AP1 protein pattern, cellular oxidative stress and hepatic copper accumulation. J Inherit Metab Dis. 2020;43:694\u2013700.","journal-title":"J Inherit Metab Dis"},{"key":"728_CR88","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1093\/hmg\/ddt180","volume":"22","author":"O Korvatska","year":"2013","unstructured":"Korvatska O, et al. Altered splicing of ATP6AP2 causes X-linked parkinsonism with spasticity (XPDS). Hum Mol Genet. 2013;22:3259\u201368.","journal-title":"Hum Mol Genet"},{"key":"728_CR89","doi-asserted-by":"publisher","first-page":"6736","DOI":"10.1093\/hmg\/ddv380","volume":"24","author":"A Dubos","year":"2015","unstructured":"Dubos A, et al. Conditional depletion of intellectual disability and parkinsonism candidate gene ATP6AP2 in fly and mouse induces cognitive impairment and neurodegeneration. Hum Mol Genet. 2015;24:6736\u201355.","journal-title":"Hum Mol Genet"},{"key":"728_CR90","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/hmg\/ddi094","volume":"14","author":"J Ramser","year":"2005","unstructured":"Ramser J, et al. A unique exonic splice enhancer mutation in a family with X-linked mental retardation and epilepsy points to a novel role of the Renin receptor. Hum Mol Genet. 2005;14:1019\u201327.","journal-title":"Hum Mol Genet"},{"key":"728_CR91","doi-asserted-by":"crossref","unstructured":"Hunter WG et al. Metabolomic profiling identifies novel Circulating biomarkers of mitochondrial dysfunction differentially elevated in heart failure with preserved versus reduced ejection fraction: evidence for shared metabolic impairments in clinical heart failure. J Am Hear Assoc. 2016;5.","DOI":"10.1161\/JAHA.115.003190"},{"key":"728_CR92","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1001\/jama.2020.10262","volume":"324","author":"SP Murphy","year":"2020","unstructured":"Murphy SP, Ibrahim NE, Januzzi JL. Heart failure with reduced ejection fraction. JAMA. 2020;324:488.","journal-title":"JAMA"},{"key":"728_CR93","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1161\/CIRCRESAHA.121.318158","volume":"128","author":"DL Mann","year":"2021","unstructured":"Mann DL, Felker GM. Mechanisms and models in heart failure. Circ Res. 2021;128:1435\u201350.","journal-title":"Circ Res"},{"key":"728_CR94","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","volume":"128","author":"GD Lopaschuk","year":"2021","unstructured":"Lopaschuk GD, Karwi QG, Tian R, Wende AR, Abel ED. Cardiac energy metabolism in heart failure. Circ Res. 2021;128:1487\u2013513.","journal-title":"Circ Res"},{"key":"728_CR95","doi-asserted-by":"crossref","unstructured":"Ferro F, Spelat R, Valente C, Contessotto P. Understanding how heart metabolic derangement shows differential stage specificity for heart failure with preserved and reduced ejection fraction. Biomolecules 2022;12.","DOI":"10.3390\/biom12070969"},{"key":"728_CR96","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10557-022-07355-7","volume":"37","author":"MK Burrage","year":"2023","unstructured":"Burrage MK, Lewis AJ, Miller JJJ. Functional and metabolic imaging in heart failure with preserved ejection fraction: Promises, Challenges, and clinical utility. Cardiovasc Drugs Ther. 2023;37:379\u201399.","journal-title":"Cardiovasc Drugs Ther"},{"key":"728_CR97","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/eurheartj\/ehaa841","volume":"42","author":"JAJ Verdonschot","year":"2021","unstructured":"Verdonschot JAJ, et al. Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differences. Eur Hear J. 2021;42:162\u201374.","journal-title":"Eur Hear J"},{"key":"728_CR98","doi-asserted-by":"publisher","first-page":"4269","DOI":"10.1093\/eurheartj\/ehy712","volume":"39","author":"J Tromp","year":"2018","unstructured":"Tromp J, et al. Novel endotypes in heart failure: effects on guideline-directed medical therapy. Eur Heart J. 2018;39:4269\u201376.","journal-title":"Eur Heart J"},{"key":"728_CR99","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.phrs.2016.06.027","volume":"111","author":"AM Koning","year":"2016","unstructured":"Koning AM, et al. Serum free thiols in chronic heart failure. Pharmacol Res. 2016;111:452\u20138.","journal-title":"Pharmacol Res"},{"key":"728_CR100","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0735-1097(02)01967-8","volume":"40","author":"VG D\u00e1vila-Rom\u00e1n","year":"2002","unstructured":"D\u00e1vila-Rom\u00e1n VG, et al. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 2002;40:271\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"728_CR101","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ahj.2016.02.014","volume":"175","author":"Y Arbel","year":"2016","unstructured":"Arbel Y, et al. Association between publication of appropriate use criteria and the Temporal trends in diagnostic angiography in stable coronary artery disease: A population-based study. Am Hear J. 2016;175:153\u20139.","journal-title":"Am Hear J"},{"key":"728_CR102","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1021\/acssensors.0c00103","volume":"5","author":"KV Kilchrist","year":"2020","unstructured":"Kilchrist KV, Tierney JW, Duvall CL. Genetically encoded split-Luciferase biosensors to measure endosome disruption rapidly in live cells. ACS Sens. 2020;5:1929\u201336.","journal-title":"ACS Sens"},{"key":"728_CR103","doi-asserted-by":"crossref","unstructured":"Lohith TG et al. Radiosynthesis and early evaluation of a positron emission tomography imaging probe [18F]AGAL targeting alpha-galactosidase A enzyme for Fabry disease. Molecules 2023;28.","DOI":"10.3390\/molecules28207144"},{"key":"728_CR104","doi-asserted-by":"crossref","unstructured":"Coukos R et al. An engineered transcriptional reporter of protein localization identifies regulators of mitochondrial and ER membrane protein trafficking in high-throughput CRISPRi screens. Elife 2021;10.","DOI":"10.7554\/eLife.69142"},{"key":"728_CR105","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1021\/ar200063v","volume":"44","author":"HC Hang","year":"2011","unstructured":"Hang HC, Wilson JP, Charron G. Bioorthogonal chemical reporters for analyzing protein lipidation and lipid trafficking. Acc Chem Res. 2011;44:699\u2013708.","journal-title":"Acc Chem Res"},{"key":"728_CR106","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/tra.12722","volume":"21","author":"LA Perkins","year":"2020","unstructured":"Perkins LA, Bruchez MP. Fluorogen activating protein toolset for protein trafficking measurements. Traffic. 2020;21:333\u201348.","journal-title":"Traffic"},{"key":"728_CR107","doi-asserted-by":"publisher","first-page":"153601211984602","DOI":"10.1177\/1536012119846025","volume":"18","author":"X Li","year":"2019","unstructured":"Li X, Wang D, Yu L. Prognostic and predictive values of metabolic parameters of 18F-FDG PET\/CT in patients with non-small cell lung cancer treated with chemotherapy. Mol Imaging. 2019;18:1536012119846025.","journal-title":"Mol Imaging"},{"key":"728_CR108","doi-asserted-by":"publisher","first-page":"276","DOI":"10.2967\/jnumed.119.229567","volume":"61","author":"LK Shiyam Sundar","year":"2020","unstructured":"Shiyam Sundar LK, et al. Promise of fully integrated PET\/MRI: noninvasive clinical quantification of cerebral glucose metabolism. J Nucl Med. 2020;61:276\u201384.","journal-title":"J Nucl Med"},{"key":"728_CR109","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1016\/j.cub.2016.06.046","volume":"26","author":"NA Bright","year":"2016","unstructured":"Bright NA, Davis LJ, Luzio JP. Endolysosomes are the principal intracellular sites of acid hydrolase activity. Curr Biol. 2016;26:2233\u201345.","journal-title":"Curr Biol"},{"key":"728_CR110","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1093\/brain\/awy092","volume":"141","author":"A Fassio","year":"2018","unstructured":"Fassio A, et al. De Novo mutations of the ATP6V1A gene cause developmental encephalopathy with epilepsy. Brain. 2018;141:1703\u201318.","journal-title":"Brain"},{"key":"728_CR111","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1039\/C4TB01878H","volume":"3","author":"J Zhang","year":"2015","unstructured":"Zhang J, et al. Near-infrared fluorescent probes based on piperazine-functionalized BODIPY dyes for sensitive detection of lysosomal pH. J Mater Chem B. 2015;3:2173\u201384.","journal-title":"J Mater Chem B"},{"key":"728_CR112","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1073\/pnas.92.8.3156","volume":"92","author":"CC Overly","year":"1995","unstructured":"Overly CC, Lee KD, Berthiaume E, Hollenbeck PJ. Quantitative measurement of intraorganelle pH in the endosomal-lysosomal pathway in neurons by using ratiometric imaging with pyranine. Proc Natl Acad Sci. 1995;92:3156\u201360.","journal-title":"Proc Natl Acad Sci."},{"key":"728_CR113","doi-asserted-by":"publisher","first-page":"20220387","DOI":"10.1098\/rstb.2022.0387","volume":"379","author":"M Herman","year":"2024","unstructured":"Herman M, Randall GW, Spiegel JL, Maldonado DJ, Simoes S. Endo-lysosomal dysfunction in neurodegenerative diseases: opinion on current progress and future direction in the use of exosomes as biomarkers. Philos Trans R Soc Lond B Biol Sci. 2024;379:20220387.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"728_CR114","doi-asserted-by":"publisher","first-page":"7371","DOI":"10.3390\/ijms25137371","volume":"25","author":"G Zanirati","year":"2024","unstructured":"Zanirati G, et al. Extracellular vesicles: the next generation of biomarkers and treatment for central nervous system diseases. Int J Mol Sci. 2024;25:7371.","journal-title":"Int J Mol Sci"},{"key":"728_CR115","doi-asserted-by":"publisher","first-page":"27333","DOI":"10.18632\/oncotarget.25542","volume":"9","author":"G Cammarata","year":"2018","unstructured":"Cammarata G, et al. A pilot study of Circulating MicroRNAs as potential biomarkers of Fabry disease. Oncotarget. 2018;9:27333\u201345.","journal-title":"Oncotarget"},{"key":"728_CR116","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1378\/chest.15-0799","volume":"149","author":"A Khalyfa","year":"2016","unstructured":"Khalyfa A, Kheirandish-Gozal L, Bhattacharjee R, Khalyfa AA, Gozal D. Circulating MicroRNAs as potential biomarkers of endothelial dysfunction in obese children. Chest. 2016;149:786\u2013800.","journal-title":"Chest"},{"key":"728_CR117","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1002\/ejhf.1674","volume":"22","author":"MF Hoes","year":"2020","unstructured":"Hoes MF, et al. The role of cathepsin D in the pathophysiology of heart failure and its potentially beneficial properties: a translational approach. Eur J Heart Fail. 2020;22:2102\u201311.","journal-title":"Eur J Heart Fail"},{"key":"728_CR118","doi-asserted-by":"publisher","first-page":"6211","DOI":"10.21037\/jtd.2018.10.52","volume":"10","author":"T Wu","year":"2018","unstructured":"Wu T, et al. Circulating Exosomal miR-92b-5p is a promising diagnostic biomarker of heart failure with reduced ejection fraction patients hospitalized for acute heart failure. J Thorac Dis. 2018;10:6211\u201320.","journal-title":"J Thorac Dis"},{"key":"728_CR119","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.cmet.2019.07.011","volume":"30","author":"MA Mori","year":"2019","unstructured":"Mori MA, Ludwig RG, Garcia-Martin R, Brand\u00e3o BB, Kahn CR. Extracellular mirnas: from biomarkers to mediators of physiology and disease. Cell Metab. 2019;30:656\u201373.","journal-title":"Cell Metab"},{"key":"728_CR120","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1194\/jlr.R084640","volume":"59","author":"E Boilard","year":"2018","unstructured":"Boilard E. Extracellular vesicles and their content in bioactive lipid mediators: more than a sack of MicroRNA. J Lipid Res. 2018;59:2037\u201346.","journal-title":"J Lipid Res"},{"key":"728_CR121","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1194\/jlr.M003657","volume":"51","author":"C Subra","year":"2010","unstructured":"Subra C, et al. Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins. J Lipid Res. 2010;51:2105\u201320.","journal-title":"J Lipid Res"},{"key":"728_CR122","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.freeradbiomed.2021.05.018","volume":"172","author":"Y Liao","year":"2021","unstructured":"Liao Y, et al. Advanced oxidation protein products impair autophagic flux in macrophage by inducing lysosomal dysfunction via activation of PI3K-Akt-mTOR pathway in crohn\u2019s disease. Free Radic Biol Med. 2021;172:33\u201347.","journal-title":"Free Radic Biol Med"},{"key":"728_CR123","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.3512167","author":"A Pensalfini","year":"2019","unstructured":"Pensalfini A, et al. Endosomal dysfunction induced by directly over-activating Rab5 recapitulates prodromal and neurodegenerative features of alzheimer\u2019s disease. SSRN Electron J. 2019. https:\/\/doi.org\/10.2139\/ssrn.3512167.","journal-title":"SSRN Electron J"},{"key":"728_CR124","doi-asserted-by":"crossref","unstructured":"Indrawinata K, Argiropoulos P, Sugita S. Structural and functional Understanding of disease-associated mutations in V-ATPase subunit a1 and other isoforms. Front Mol Neurosci 2023;16.","DOI":"10.3389\/fnmol.2023.1135015"},{"key":"728_CR125","doi-asserted-by":"publisher","first-page":"7075","DOI":"10.1074\/jbc.RA120.012614","volume":"295","author":"A Ilie","year":"2020","unstructured":"Ilie A, et al. Assorted dysfunctions of endosomal alkali cation\/proton exchanger SLC9A6 variants linked to Christianson syndrome. J Biol Chem. 2020;295:7075\u201395.","journal-title":"J Biol Chem"},{"key":"728_CR126","doi-asserted-by":"publisher","first-page":"a006195","DOI":"10.1101\/mcs.a006195","volume":"8","author":"S Barua","year":"2022","unstructured":"Barua S, Berger S, Pereira EM, Jobanputra V. Expanding the phenotype of ATP6AP1 deficiency. Mol Case Stud. 2022;8:a006195.","journal-title":"Mol Case Stud"},{"key":"728_CR127","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1084\/jem.20170453","volume":"214","author":"MA Rujano","year":"2017","unstructured":"Rujano MA, et al. Mutations in the X-linked ATP6AP2 cause a glycosylation disorder with autophagic defects. J Exp Med. 2017;214:3707\u201329.","journal-title":"J Exp Med"},{"key":"728_CR128","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1681\/ASN.2005121277","volume":"17","author":"Q Yang","year":"2006","unstructured":"Yang Q, Li G, Singh SK, Alexander EA, Schwartz JH. Vacuolar H+-ATPase B1 subunit mutations that cause inherited distal renal tubular acidosis affect proton pump assembly and trafficking in inner medullary collecting duct cells. J Am Soc Nephrol. 2006;17:1858\u201366.","journal-title":"J Am Soc Nephrol"},{"key":"728_CR129","doi-asserted-by":"publisher","first-page":"7189","DOI":"10.1038\/s41598-020-64031-2","volume":"10","author":"R Nagrani","year":"2020","unstructured":"Nagrani R, et al. Common genetic variation in obesity, lipid transfer genes and risk of metabolic syndrome: results from IDEFICS\/I.Family study and meta-analysis. Sci Rep. 2020;10:7189.","journal-title":"Sci Rep"},{"key":"728_CR130","doi-asserted-by":"publisher","first-page":"120806","DOI":"10.1016\/j.lfs.2022.120806","volume":"306","author":"J Liu","year":"2022","unstructured":"Liu J, Zheng X, Wu X. The Rab GTPase in the heart: pivotal roles in development and disease. Life Sci. 2022;306:120806.","journal-title":"Life Sci"},{"key":"728_CR131","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1080\/21541248.2017.1397833","volume":"9","author":"MJ Banworth","year":"2018","unstructured":"Banworth MJ, Li G. Consequences of Rab GTPase dysfunction in genetic or acquired human diseases. Small GTPases. 2018;9:158\u201381.","journal-title":"Small GTPases"},{"key":"728_CR132","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00431-008-0740-z","volume":"167","author":"L Corbeel","year":"2008","unstructured":"Corbeel L, Freson K. Rab proteins and Rab-associated proteins: major actors in the mechanism of protein-trafficking disorders. Eur J Pediatr. 2008;167:723\u20139.","journal-title":"Eur J Pediatr"},{"key":"728_CR133","doi-asserted-by":"publisher","first-page":"909","DOI":"10.3390\/cells8080909","volume":"8","author":"NA Guadagno","year":"2019","unstructured":"Guadagno NA, Progida C. Rab gtpases: switching to human diseases. Cells. 2019;8:909.","journal-title":"Cells"},{"key":"728_CR134","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1016\/j.yexcr.2013.06.012","volume":"319","author":"K Krzewski","year":"2013","unstructured":"Krzewski K, Cullinane AR. Evidence for defective Rab GTPase-dependent cargo traffic in immune disorders. Exp Cell Res. 2013;319:2360\u20137.","journal-title":"Exp Cell Res"},{"key":"728_CR135","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1183\/09031936.00001711","volume":"38","author":"S Hofmann","year":"2011","unstructured":"Hofmann S, et al. A genome-wide association study reveals evidence of association with sarcoidosis at 6p12.1. Eur Respir J. 2011;38:1127\u201335.","journal-title":"Eur Respir J"},{"key":"728_CR136","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10545-017-0131-6","volume":"41","author":"KLM Coene","year":"2018","unstructured":"Coene KLM, et al. Next-generation metabolic screening: targeted and untargeted metabolomics for the diagnosis of inborn errors of metabolism in individual patients. J Inherit Metab Dis. 2018;41:337\u201353.","journal-title":"J Inherit Metab Dis"},{"key":"728_CR137","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s10545-018-0139-6","volume":"41","author":"E Graham","year":"2018","unstructured":"Graham E, et al. Integration of genomics and metabolomics for prioritization of rare disease variants: a 2018 literature review. J Inherit Metab Dis. 2018;41:435\u201345.","journal-title":"J Inherit Metab Dis"},{"key":"728_CR138","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.tig.2021.07.005","volume":"37","author":"M Claussnitzer","year":"2021","unstructured":"Claussnitzer M, Susztak K. Gaining insight into metabolic diseases from human genetic discoveries. Trends Genet. 2021;37:1081\u201394.","journal-title":"Trends Genet"},{"key":"728_CR139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00424-003-1199-4","volume":"448","author":"JJFP Luiken","year":"2004","unstructured":"Luiken JJFP, et al. Regulation of cardiac long-chain fatty acid and glucose uptake by translocation of substrate transporters. Pfl\u00fcgers Arch. 2004;448:1\u201315.","journal-title":"Pfl\u00fcgers Arch"},{"key":"728_CR140","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41569-018-0044-6","volume":"15","author":"E Bertero","year":"2018","unstructured":"Bertero E, Maack C. Metabolic remodelling in heart failure. Nat Rev Cardiol. 2018;15:457\u201370.","journal-title":"Nat Rev Cardiol"},{"key":"728_CR141","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1096\/fj.04-2263com","volume":"18","author":"S Sharma","year":"2004","unstructured":"Sharma S, et al. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J. 2004;18:1692\u2013700.","journal-title":"FASEB J"},{"key":"728_CR142","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1152\/physrev.00017.2007","volume":"88","author":"ED Abel","year":"2008","unstructured":"Abel ED, Litwin SE, Sweeney G. Cardiac remodeling in obesity. Physiol Rev. 2008;88:389\u2013419.","journal-title":"Physiol Rev"},{"key":"728_CR143","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1074\/jbc.270.4.1557","volume":"270","author":"WJ Dschida","year":"1995","unstructured":"Dschida WJ, Bowman BJ. The vacuolar atpase: sulfite stabilization and the mechanism of nitrate inactivation. J Biol Chem. 1995;270:1557\u201363.","journal-title":"J Biol Chem"},{"key":"728_CR144","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.bbrc.2018.03.227","volume":"499","author":"H Kim","year":"2018","unstructured":"Kim H, et al. Cardiac-specific delivery by cardiac tissue-targeting peptide-expressing exosomes. Biochem Biophys Res Commun. 2018;499:803\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"728_CR145","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3389\/fbioe.2020.00687","volume":"8","author":"C Fan","year":"2020","unstructured":"Fan C, et al. Nanoparticle-mediated drug delivery for treatment of ischemic heart disease. Front Bioeng Biotechnol. 2020;8:687.","journal-title":"Front Bioeng Biotechnol"},{"key":"728_CR146","doi-asserted-by":"publisher","first-page":"1705134","DOI":"10.1002\/adfm.201705134","volume":"28","author":"MPA Ferreira","year":"2018","unstructured":"Ferreira MPA, et al. Dual-drug delivery using dextran-functionalized nanoparticles targeting cardiac fibroblasts for cellular reprogramming. Adv Funct Mater. 2018;28:1705134.","journal-title":"Adv Funct Mater"},{"key":"728_CR147","doi-asserted-by":"publisher","first-page":"113677","DOI":"10.1016\/j.bcp.2019.113677","volume":"170","author":"A Arag\u00f3n-Herrera","year":"2019","unstructured":"Arag\u00f3n-Herrera A, et al. Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats. Biochem Pharmacol. 2019;170:113677.","journal-title":"Biochem Pharmacol"},{"key":"728_CR148","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1126\/science.aaz2924","volume":"367","author":"YM Abbas","year":"2020","unstructured":"Abbas YM, Wu D, Bueler SA, Robinson CV, Rubinstein JL. Structure of V-ATPase from the mammalian brain. Sci (80-). 2020;367:1240\u20136.","journal-title":"Sci (80-)"},{"key":"728_CR149","doi-asserted-by":"publisher","first-page":"24495","DOI":"10.1074\/jbc.M702598200","volume":"282","author":"M Lu","year":"2007","unstructured":"Lu M, Ammar D, Ives H, Albrecht F, Gluck SL. Physical interaction between aldolase and vacuolar H+-ATPase is essential for the assembly and activity of the proton pump. J Biol Chem. 2007;282:24495\u2013503.","journal-title":"J Biol Chem"},{"key":"728_CR150","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/s41422-020-00456-8","volume":"31","author":"M Li","year":"2021","unstructured":"Li M, et al. Aldolase is a sensor for both low and high glucose, linking to AMPK and mTORC1. Cell Res. 2021;31:478\u201381.","journal-title":"Cell Res"},{"key":"728_CR151","doi-asserted-by":"publisher","first-page":"15820","DOI":"10.1074\/jbc.M116.717488","volume":"291","author":"C-Y Chan","year":"2016","unstructured":"Chan C-Y, Dominguez D, Parra KJ. Regulation of vacuolar H+-ATPase (V-ATPase) reassembly by Glycolysis flow in 6-phosphofructo-1-kinase (PFK-1)-deficient yeast cells. J Biol Chem. 2016;291:15820\u20139.","journal-title":"J Biol Chem"},{"key":"728_CR152","doi-asserted-by":"crossref","unstructured":"Wen D-T, Zheng L, Lu K, Hou W-Q. Activation of cardiac Nmnat\/NAD+\/SIR2 pathways mediates endurance exercise resistance to lipotoxic cardiomyopathy in aging drosophila. J Exp Biol 2021;224.","DOI":"10.1242\/jeb.242425"},{"key":"728_CR153","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cmet.2016.09.013","volume":"24","author":"KF Mills","year":"2016","unstructured":"Mills KF, et al. Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metab. 2016;24:795\u2013806.","journal-title":"Cell Metab"},{"key":"728_CR154","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1093\/cvr\/cvp017","volume":"82","author":"JJ Wright","year":"2009","unstructured":"Wright JJ, et al. Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding. Cardiovasc Res. 2009;82:351\u201360.","journal-title":"Cardiovasc Res"},{"key":"728_CR155","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1152\/physrev.00003.2009","volume":"90","author":"JFC Glatz","year":"2010","unstructured":"Glatz JFC, Luiken JJFP, Bonen A. Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease. Physiol Rev. 2010;90:367\u2013417.","journal-title":"Physiol Rev"},{"key":"728_CR156","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1016\/S0140-6736(10)60408-4","volume":"375","author":"VT Samuel","year":"2010","unstructured":"Samuel VT, Petersen KF, Shulman G. I. Lipid-induced insulin resistance: unravelling the mechanism. Lancet. 2010;375:2267\u201377.","journal-title":"Lancet"},{"key":"728_CR157","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cmet.2015.01.016","volume":"21","author":"ZV Wang","year":"2015","unstructured":"Wang ZV, Hill JA. Protein quality control and metabolism: bidirectional control in the heart. Cell Metab. 2015;21:215\u201326.","journal-title":"Cell Metab"},{"key":"728_CR158","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coisb.2017.05.019","volume":"6","author":"A Richelle","year":"2017","unstructured":"Richelle A, Lewis NE. Improvements in protein production in mammalian cells from targeted metabolic engineering. Curr Opin Syst Biol. 2017;6:1\u20136.","journal-title":"Curr Opin Syst Biol"},{"key":"728_CR159","doi-asserted-by":"publisher","first-page":"106244","DOI":"10.1016\/j.nbd.2023.106244","volume":"185","author":"L Wu","year":"2023","unstructured":"Wu L, et al. TMEM175: A lysosomal ion channel associated with neurological diseases. Neurobiol Dis. 2023;185:106244.","journal-title":"Neurobiol Dis"}],"container-title":["Current Heart Failure Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-025-00728-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11897-025-00728-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-025-00728-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:02:22Z","timestamp":1768550542000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11897-025-00728-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":159,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["728"],"URL":"https:\/\/doi.org\/10.1007\/s11897-025-00728-7","relation":{},"ISSN":["1546-9530","1546-9549"],"issn-type":[{"value":"1546-9530","type":"print"},{"value":"1546-9549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"18 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All reported studies\/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional\/national research committee standards, and international\/national\/institutional guidelines).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}